SCHEMBL3262841

SCHEMBL3262841

COc1ccc(C(=O)NCCc2c(C)[nH]c3ccc(OC(F)(F)Cl)cc23)cc1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.56
LMNA P02545 2/20 0.56
MTNR1A P48039 3/20 0.55
MTNR1B P49286 3/20 0.55
MEN1 O00255 5/20 0.53
KMT2A Q03164 5/20 0.53
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 1/20 0.48
MAPK1 P28482 1/20 0.48
TLR7 Q9NYK1 3/20 0.47
TLR8 Q9NR97 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
TLR9 Q9NR96 1/20 0.47
SNCA P37840 1/20 0.47
POLB P06746 1/20 0.47
HTT P42858 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
TRPV1 Q8NER1 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3382808 0.93 MEN1 (0.61) MAPTLMNAMTNR1AMTNR1BMEN1
SCHEMBL3235282 0.89 MTNR1A (0.69) MAPTLMNAMTNR1AMTNR1BMEN1
SCHEMBL3232656 0.84 MAPT (0.63) MAPTLMNAMTNR1AMTNR1BMEN1
SCHEMBL3385338 0.84 MEN1 (0.61) MAPTMTNR1AMTNR1BMEN1KMT2A
SCHEMBL3384642 0.83 MTNR1A (0.64) MAPTLMNAMTNR1AMTNR1BMEN1
SCHEMBL3230797 0.81 ATM (0.66) MAPTLMNAMEN1KMT2AKDM4E
SCHEMBL3382278 0.80 MEN1 (0.54) MAPTMTNR1AMTNR1BMEN1KMT2A
SCHEMBL3227065 0.80 MTNR1A (0.77) MAPTLMNAMTNR1AMTNR1BMEN1
SCHEMBL3384980 0.79 MEN1 (0.61) MAPTMTNR1AMTNR1BMEN1KMT2A
SCHEMBL3227925 0.79 MTNR1A (0.69) MAPTLMNAMTNR1AMTNR1BMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010012396-A1 5,6 SUBSTITUTED BENZAMIDE DERIVATIVES AS MODULATORS OF THE EP<SB>2 </SB>RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-02-04 WO claimed
EP-2149552-A1 5,6 substituted benzamide derivatives as modulators of EP2 receptors Bayer Schering Pharma AG (DE) 2010-02-03 EP claimed
WO-2010012396-A1 5,6 SUBSTITUTED BENZAMIDE DERIVATIVES AS MODULATORS OF THE EP<SB>2 </SB>RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-02-04 WO disclosed
EP-2149552-A1 5,6 substituted benzamide derivatives as modulators of EP2 receptors Bayer Schering Pharma AG (DE) 2010-02-03 EP disclosed
EP-2149552-A1 5,6 substituted benzamide derivatives as modulators of EP2 receptors Bayer Schering Pharma AG (DE) 2010-02-03 EP disclosed